Epidemiology of borderline oxacillin‐resistant Staphylococcus aureus in Pediatric cystic fibrosis
- 17 February 2011
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 46 (5), 489-496
- https://doi.org/10.1002/ppul.21383
Abstract
A single‐center retrospective study was undertaken in children with cystic fibrosis (CF) to evaluate (1) risk factors for acquisition; (2) molecular epidemiology; and (3) impact on disease progression of borderline oxacillin‐resistant Staphylococcus aureus (BORSA) versus mecA‐positive methicillin‐resistant Staphylococcus aureus (MRSA). The study comprised of (1) identification of all children with at least one respiratory specimen positive for either BORSA or MRSA during the study period; (2) compilation of relevant clinical and epidemiological data from 12‐month period leading up to first positive (index) culture; (3) microbiological and molecular characterization of index isolates and (4) measurement of subsequent clinical outcome. Thirty‐eight children were identified with at least one positive isolate; 4 were excluded due to insufficient clinical or laboratory data. Eighteen children (53%) grew BORSA in their index culture. Children who acquired BORSA only (n = 16) were more likely to have had prior MSSA colonization (P < 0.0001). Usage of oral cephalexin (P < 0.01) and inhaled tobramycin (P < 0.03) prior to index culture was significantly and independently associated with acquisition of BORSA. The majority of BORSA isolates were hyper β‐lactamase producers and susceptible to a greater range of antibiotics. Strain relatedness was not evident within the BORSA group. There was no difference in disease progression between the two groups. This is the first study to demonstrate that a significant proportion of S. aureus isolates with methicillin resistance in the CF population are BORSAs that lack mecA. Antibiotic pressure may lead to the development of BORSA in CF patients. Prospective studies are needed to assess its clinical impact. Pediatr. Pulmonol. 2011; 46:489–496.Keywords
Funding Information
- none reported
This publication has 30 references indexed in Scilit:
- Prevalence of Community-Associated Methicillin-Resistant Staphylococcus aureus in Patients with Cystic FibrosisJournal of Clinical Microbiology, 2009
- Failure of Cloxacillin in Treatment of a Patient with Borderline Oxacillin-Resistant Staphylococcus aureus EndocarditisJournal of Clinical Microbiology, 2009
- Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung functionPediatric Pulmonology, 2007
- Community Case of Methicillin-resistantStaphylococcus aureusInfectionEmerging Infectious Diseases, 2006
- Community-associated Methicillin-resistantStaphylococcus aureus, CanadaEmerging Infectious Diseases, 2005
- Effect of continuous antistaphylococcal therapy on the rate ofP. aeruginosa acquisition in patients with cystic fibrosisPediatric Pulmonology, 2001
- Methicillin-resistant Staphylococcus aureus in a cystic fibrosis unitJournal of Hospital Infection, 1997
- Tracking the Evolutionary Origin of the Methicillin Resistance Gene: Cloning and Sequencing of a Homologue ofmecAfrom a Methicillin Susceptible Strain ofStaphylococcus sciuriMicrobial Drug Resistance, 1996
- Evidence for a Clonal Origin of Methicillin Resistance in Staphylococcus aureusScience, 1993
- Implications of Acquired Oxacillin Resistance in the Management and Control of Staphylococcus aureus InfectionsThe Journal of Infectious Diseases, 1988